Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Bill

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Bone Marrow Transplantation|January 14, 2022
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantationJohannes Frasez Soerensen, Anni Aggerholm, Carina Agerbo Rosenberg, et al.
International Journal of Molecular Sciences|June 27, 2024
Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid LeukemiaTrine Engelbrecht Hybel, Sofie Hesselberg Jensen, Matthew A Rodrigues, et al.
Blood Advances|March 10, 2020
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantationJohannes Frasez Soerensen, Anni Aggerholm, Gitte Birk Kerndrup, et al.
Leukemia|July 18, 2023
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivoSigne Neldeborg, Johannes Frasez Soerensen, Charlotte Thornild Møller, et al.
Journal of Clinical Immunology|September 30, 2025
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-ScoreLasse von Bornemann Fløe, Kirstine Overgaard Dyrmose, Camilla Darum Sørensen, et al.
Nature Cancer|October 2, 2023
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivoEirini Giannakopoulou, Madeleine Lehander, Stina Virding Culleton, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Bone Marrow Transplantation|January 14, 2022
Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantationJohannes Frasez Soerensen, Anni Aggerholm, Carina Agerbo Rosenberg, et al.
International Journal of Molecular Sciences|June 27, 2024
Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid LeukemiaTrine Engelbrecht Hybel, Sofie Hesselberg Jensen, Matthew A Rodrigues, et al.
Blood Advances|March 10, 2020
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantationJohannes Frasez Soerensen, Anni Aggerholm, Gitte Birk Kerndrup, et al.
Leukemia|July 18, 2023
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivoSigne Neldeborg, Johannes Frasez Soerensen, Charlotte Thornild Møller, et al.
Journal of Clinical Immunology|September 30, 2025
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-ScoreLasse von Bornemann Fløe, Kirstine Overgaard Dyrmose, Camilla Darum Sørensen, et al.
Nature Cancer|October 2, 2023
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivoEirini Giannakopoulou, Madeleine Lehander, Stina Virding Culleton, et al.
Pageof 2